LOZZI, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 15.763
EU - Europa 6.670
AS - Asia 3.270
SA - Sud America 607
AF - Africa 50
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 8
Totale 26.384
Nazione #
US - Stati Uniti d'America 15.674
GB - Regno Unito 1.556
CN - Cina 1.498
RU - Federazione Russa 1.351
IE - Irlanda 937
SG - Singapore 872
UA - Ucraina 640
SE - Svezia 580
BR - Brasile 512
DE - Germania 490
IT - Italia 374
FR - Francia 305
HK - Hong Kong 257
KR - Corea 206
FI - Finlandia 190
VN - Vietnam 156
IN - India 77
ES - Italia 66
CA - Canada 45
AR - Argentina 43
BE - Belgio 34
PL - Polonia 30
JP - Giappone 26
NL - Olanda 26
TR - Turchia 26
BD - Bangladesh 25
MX - Messico 22
RO - Romania 18
CZ - Repubblica Ceca 17
AT - Austria 15
IR - Iran 15
AU - Australia 14
CI - Costa d'Avorio 14
PK - Pakistan 14
IQ - Iraq 12
EC - Ecuador 11
ZA - Sudafrica 10
JO - Giordania 9
PY - Paraguay 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
EU - Europa 8
ID - Indonesia 8
IL - Israele 7
PH - Filippine 7
AZ - Azerbaigian 6
LB - Libano 6
MA - Marocco 6
PE - Perù 6
SA - Arabia Saudita 6
CL - Cile 5
EG - Egitto 5
GR - Grecia 5
KE - Kenya 5
LT - Lituania 5
PA - Panama 5
RS - Serbia 5
UZ - Uzbekistan 5
BY - Bielorussia 4
JM - Giamaica 4
KZ - Kazakistan 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
KG - Kirghizistan 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CY - Cipro 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
LK - Sri Lanka 1
MY - Malesia 1
NI - Nicaragua 1
PT - Portogallo 1
Totale 26.380
Città #
Dallas 8.008
Southend 1.405
Dublin 931
Fairfield 830
Menlo Park 616
Ashburn 613
Chandler 595
Jacksonville 499
Singapore 494
Woodbridge 446
Seattle 366
Moscow 364
Wilmington 351
Beijing 350
Santa Clara 350
Houston 349
Ann Arbor 298
Cambridge 290
Hong Kong 255
Seoul 205
Hefei 204
Siena 197
Nanjing 188
Princeton 173
Los Angeles 98
New York 91
Fremont 84
Boardman 80
Shanghai 80
Munich 75
Helsinki 73
San Mateo 71
Nanchang 68
Buffalo 56
Málaga 50
São Paulo 50
San Diego 49
The Dalles 46
Dong Ket 45
Dearborn 43
Ho Chi Minh City 40
Shenyang 39
Brussels 31
Changsha 30
Hanoi 29
Hebei 29
Tianjin 29
Redwood City 28
Turku 28
Council Bluffs 26
Jiaxing 23
Kunming 23
Toronto 23
Warsaw 23
Bengaluru 22
London 21
Milan 21
Zhengzhou 21
Jinan 20
San Francisco 20
Chicago 18
Washington 18
Tokyo 17
Chennai 16
Columbus 16
Florence 16
Rio de Janeiro 15
University Park 15
Abidjan 14
Amsterdam 14
Brooklyn 14
Frankfurt am Main 14
Guangzhou 14
Orem 14
Redondo Beach 14
Lancaster 13
Belo Horizonte 12
Brasília 12
Brno 12
Kansas City 12
Ningbo 12
Timisoara 12
Denver 11
Stockholm 11
Boston 10
Hangzhou 10
Izmir 10
Norwalk 10
Nürnberg 10
Phoenix 10
Taizhou 10
Tappahannock 10
Amman 9
Atlanta 9
Dhaka 9
Poplar 9
Rome 9
Vienna 9
Johannesburg 8
Venezia 8
Totale 20.448
Nome #
1 H‐ and natural abundance 15 N‐nmr studies of a derivative of a rabies glycoprotein fragment 7.437
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 352
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 333
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 320
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 306
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 304
A model of the rabies virus glycoprotein active site 293
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 290
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 288
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 280
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 259
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 257
Tumor imaging with tetrabranched neurotensin 251
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 246
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 243
Affinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 242
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 238
Branched Neurotensin For Tumor Targeting 233
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 231
A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate camcer metastates, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2 228
Bioactive peptides from libraries 226
Toxin-related antibodies with antimicrobial and antiviral activity 224
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 222
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 220
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 219
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 217
Branched peptides as targeting agents for tumor imaging and therapy 215
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 213
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 209
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 209
Antigenicity of synthetic peptides derived from C100 protein of hepatitis C virus 208
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 207
Synthetic peptides in the form of dendrimers become resistant to protease activity 206
Highly fluorescent protein labeling using dendritic peptide derivatives 205
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 200
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 198
Branched neurotensin for tumor targeting 197
Dynein heavy chain related polypeptides in growing pollen tube of Nicotiana tabacum 196
Single step purification of a synthetic peptide fragment of neurofilaments by preparative high performance liquid-chromatography 195
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 195
Single step purification of a synthetic peptide fragment of neurofilaments by preparative high performance liquid chromatography 195
Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins 193
The antimicrobial peptide M33. An example of drug development 190
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 187
Binding of HIV-1 gp120 to the nicotinic receptor 187
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 187
Molecular basis of branched peptides resistance to enzyme proteolysis 187
Synthetic peptides of rubella E1 glycoprotein for serological assays 186
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 185
A novel mimetic antigen eliciting protective antibody to Neisseria Meningitidis 184
Interaction of Angiotensin II with the C-terminal 300-320 fragment of the rat Angiotensin II Receptor AT1a monitored by NMR 181
CD and NMR structural characterization of ceratotoxins, natural peptides with antimicrobial activity 181
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 181
Tumor selective targeting by branched peptides 180
Peptide-protein interactions studied by surface plasmon and nuclear magnetic resonances 179
Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides 177
High molecular weight polypeptides related to dynein heavy chains in Nicotiana tabacum pollen tubes 177
The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies 174
Surface Plasmon Resonance analysis of HIV-1 gp 120 binding to muscle nicotinic receptors 174
On the structural stability of a small bioactive peptide of potential use in biotechnology 173
Micro-determination of amino acid composition of proteins electroblotted onto polyvinylidene difluoride membranes 172
The 208-222 region of the peplomer glycoprotein putative binding site of the rabiesvirus with the nicotinic acetylcholine receptor 171
Structure and antigenic activity of rubella E1 glycoprotein synthetic peptides 170
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 167
Antigenic recognition of pertussis and cholera toxin by the same antipeptide antibodies 166
Epitopes identification by limited proteolysis 164
Synthetic antidotes against snake neurotoxins 163
Selection of catalytically active biotin ligase and trypsin mutants by phage display 163
SNARE motif and neurotoxins 161
Toxin-related antibodies with antimicrobial and antiviral activity 161
The antimicrobial peptide M33. An example of drug development 156
Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution 154
Recognition of CMV pp65 protein antigen by human CD4 T cell lines induced with an immunodominant peptide pool 153
Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies 151
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 151
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 149
NMR structure of alpha-bungarotoxin free and bound to a mimotope of the nicotinic acetylcholine receptor 148
Tumor imaging with tetrabranched neurotensin 147
Branched neurotensin peptides for tumor targeting 145
Synthesis and purification of site-specific peptide conjugated to bovine pancreatic trypsin inhibitor 145
Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85 144
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 142
Polipeptidi correlati alle catene pesanti delle dineine in tubetti pollinici di Nicotiana tabacum 142
Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66 141
Dendrimeric peptides for tumor targeting 138
Natural analogue peptides of an HIV-1 GP-120 T-helper epitope antagonize response of GP-120 specific human CD4 T-cell clones 137
Resolution of Conformational Equilibria In Linear Peptides By Circular-dichroism In Cryogenic Solvents 137
Histidyl tags and structural stabilization of linear peptides 136
Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell binding site 136
A strategy for isolation af catalytic activities from repertoires of enzymes displayed on phage 133
New Developments in Heterocyclic Silyl Enol Ether Chemistry: Synthesis and Lewis Acid Mediated Reactions with Carbon Electrophiles of 2,5-bis(trimethylsiloxy)thiophene and 1-Methyl-2,5-bis(trimethylsiloxy)pyrrole 132
Synthetic peptides in the form of dendrimers can become resistant to protease activity 131
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 130
Synthetic inhibitors of anthrax lethal toxin 128
NMR studies of the interaction of alpha-bungarotoxin with a mimotope of the nicotinic acetylcholine receptor 124
Recognition of human T-leukaemia virus (HTLV-1) envelope by human CD4+ - cell lines from HTLV-1 seronegative individuals: Specificity and clonal heterogeneity 120
Structurally driven selection of human hepatitis C virus mimotopes. 118
On the structural stability of a small bioactive peptide of potential use in biotechnology 118
Role of manganese in MG-63 osteosarcoma cell attachment to fibrinogen and von Willabrand factor 112
STRONG SYNTHETIC INHIBITORS OF ANTHRAX LETHAL TOXIN 110
Totale 26.236
Categoria #
all - tutte 63.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.333 0 0 0 0 0 325 92 266 222 140 155 133
2021/20221.255 78 181 89 137 58 29 54 63 44 128 119 275
2022/20232.060 125 212 251 300 213 404 27 173 192 72 73 18
2023/20241.372 36 53 144 70 50 400 485 16 3 15 10 90
2024/20252.595 68 145 274 140 299 136 70 136 203 88 291 745
2025/202611.271 501 2.679 5.956 851 1.219 65 0 0 0 0 0 0
Totale 26.523